Case: 12-1693 Document: 9 Page: 1 Filed: 10/09/2012

NOTE: This order is nonprecedential.

Wntteb ~tate~ ~ourt of §ppeaI~ for tbe jfeberaI (!Circuit

JANSSEN PHARMACEUTICALS, INC. AND JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, LLC, Plaintiffs-Appellees, v. WATSON LABORATORIES, INC. AND SANDOZ, INC., Defendants, AND

LUPIN PHARMACEUTICALS, INC. AND LUPIN LTD., Defendants-Appellants.

2012-1693

Appeal from the United States District Court for the District of New Jersey in consolidated case no. 08-CV- 5103, Judge Stanley R. Chesler.

ON MOTION

ORDER Case: 12-1693 Document: 9 Page: 2 Filed: 10/09/2012

JANSSEN PHARMACEUTICALS V. WATSON LABORATORIES 2

Lupin Pharmaceuticals, Inc. et al. (Lupin) moves to expedite the appeal, briefing, and oral argument. Lupin states that Janssen Pharmaceuticals, Inc. et al. (Janssen) oppose. Upon consideration thereof, IT Is ORDERED THAT: The motions are granted to the following extent: Lu- pin's opening brief is due no later than October 26, 2012; Janssen's brief is due no later than November 30, 2012; Lupin's reply brief and the joint appendix are due no later than December 10, 2012. No extensions of time should be anticipated. Oral argument will be scheduled by subse- quent order. FOR THE COURT

/s/ Jan Horbaly Jan Horbaly Clerk s8